Literature DB >> 16784756

Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease.

Russell H Swerdlow1, Bradley Weaver, Amy Grawey, Connie Wenger, Eric Freed, Bradford B Worrall.   

Abstract

The electron transport chain enzyme complex I may play a role in Parkinson's disease (PD) pathogenesis. Association studies considering whether or not complex I-relevant gene polymorphisms contribute to PD risk are discordant. We evaluated four complex I-relevant gene polymorphisms alternatively reported to associate and not associate with PD (tRNA(Gln) T4336C, ND1 T4216C, ND2 G5460A, and the NDUFV2 exon 2 C182T transition). Our study included 111 PD subjects and 106 controls in central Virginia. Individuals with at least one copy of the NDUFV2 182T allele were more likely to report a PD family history than non-carriers, but aside from this no positive associations were found. Indeed, the tRNA(Gln) 4336C variant occurred more frequently in controls. We also observed that individuals in both groups often carried more than one of the assayed polymorphisms, and for the first time show bigenomic polymorphic variation (between nuclear and mtDNA complex I subunit genes) commonly occurs within individuals. In an exploratory sub-analysis, more control than case women had an ND1 4216C, NDUFV2 homozygous 182C compound genotype. Complex I compound genotype variation commonly occurs and may explain why particular complex I gene polymorphisms associate with PD in some populations but not others.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784756      PMCID: PMC1713224          DOI: 10.1016/j.jns.2006.05.053

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  36 in total

1.  PD or not PD? That is the question.

Authors:  Caroline M Tanner
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

2.  Validity of family history data on PD: evidence for a family information bias.

Authors:  A Elbaz; S K McDonnell; D M Maraganore; K J Strain; D J Schaid; J H Bower; J E Ahlskog; W A Rocca
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

3.  "Familial Parkinson's disease"--a case-control study of families.

Authors:  R J Uitti; H Shinotoh; M Hayward; M Schulzer; E Mak; D B Calne
Journal:  Can J Neurol Sci       Date:  1997-05       Impact factor: 2.104

4.  Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.

Authors:  R Egensperger; S Kösel; N M Schnopp; P Mehraein; M B Graeber
Journal:  Neuropathol Appl Neurobiol       Date:  1997-08       Impact factor: 8.090

5.  Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.

Authors:  C A Taylor; M H Saint-Hilaire; L A Cupples; C A Thomas; A E Burchard; R G Feldman; R H Myers
Journal:  Am J Med Genet       Date:  1999-12-15

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.

Authors:  Joelle M van der Walt; Kristin K Nicodemus; Eden R Martin; William K Scott; Martha A Nance; Ray L Watts; Jean P Hubble; Jonathan L Haines; William C Koller; Kelly Lyons; Rajesh Pahwa; Matthew B Stern; Amy Colcher; Bradley C Hiner; Joseph Jankovic; William G Ondo; Fred H Allen; Christopher G Goetz; Gary W Small; Frank Mastaglia; Jeffrey M Stajich; Adam C McLaurin; Lefkos T Middleton; Burton L Scott; Donald E Schmechel; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Am J Hum Genet       Date:  2003-02-28       Impact factor: 11.025

9.  MITOMAP: a human mitochondrial genome database--2004 update.

Authors:  Marty C Brandon; Marie T Lott; Kevin Cuong Nguyen; Syawal Spolim; Shamkant B Navathe; Pierre Baldi; Douglas C Wallace
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

Review 10.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more
  12 in total

1.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

2.  Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's disease.

Authors:  Kenya Nishioka; Carles Vilariño-Güell; Stephanie A Cobb; Jennifer M Kachergus; Owen A Ross; Emna Hentati; Faycal Hentati; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2010-10-23       Impact factor: 4.891

Review 3.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 4.  Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.

Authors:  Russell H Swerdlow
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 5.  Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

6.  Polymorphic variation in cytochrome oxidase subunit genes.

Authors:  Jianghua Lu; Kaixuan Wang; Mariana Rodova; Raquel Esteves; Diana Berry; Lezi E; Adam Crafter; Matthew Barrett; Sandra M Cardoso; Isaac Onyango; W Davis Parker; Joseph Fontes; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese.

Authors:  Wen Zhang; Xiaogang Chen; Wei Gong; Jinsong Tang; Liwen Tan; Hao Guo; Yong-Gang Yao
Journal:  Behav Brain Funct       Date:  2010-12-29       Impact factor: 3.759

8.  Mitochondrial DNA Haplogroups and the Risk of Sporadic Parkinson's Disease in Han Chinese.

Authors:  Ya-Fang Chen; Wan-Jin Chen; Xiao-Zhen Lin; Qi-Jie Zhang; Jiang-Ping Cai; Chia-Wei Liou; Ning Wang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

9.  Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.

Authors:  Dorit Ben-Shachar; Rachel Karry
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

10.  Female genetic distribution bias in mitochondrial genome observed in Parkinson's Disease patients in northern China.

Authors:  Qiaohong Chu; Xiaoguang Luo; Xiaoni Zhan; Yan Ren; Hao Pang
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.